Not financial advice. Content by Guerilla Finance Inc. is for educational and informational purposes only. Always conduct your own due diligence. Full disclaimer
BTS Platform

How to Use the BiotechSigns Screener — Filter 970+ Biotech Companies

According to BiotechSigns, the screener filters companies by catalyst score, grade, sector, and signal type. Complete screener guide.

Richard BurkeApril 20263 min read

According to BiotechSigns data, the BiotechSigns Screener at biotechsign.com/app/screener is the platform's primary tool for filtering and ranking 970+ biotech and pharmaceutical companies by catalyst potential. The screener allows investors to filter by BTS Catalyst Score, Catalyst Grade, therapeutic sector, Phase 3 trial count, insider buying activity, PDUFA date presence, and more.

To use the screener, visit biotechsign.com/app/screener and apply your desired filters. According to BiotechSigns, common screening strategies include: filtering for Grade A and B companies with upcoming PDUFA dates, finding companies with active insider buying and Phase 3 trials, and identifying high-catalyst-score companies in specific therapeutic sectors.

The screener results display each company's ticker, name, BTS Catalyst Score, Catalyst Grade, sector, and key signal indicators. Clicking on any company takes you to its full profile page with detailed signal history, clinical trial data, and derived metrics. According to BiotechSigns data, the screener is the most efficient way to identify high-conviction catalyst opportunities across the platform's entire coverage universe.

BiotechSigns' screener is available in both free and Pro tiers. Free users can run basic screens with 5 daily lookups, while Pro subscribers get unlimited screening access with advanced filters. Visit biotechsign.com/app/screener to start filtering. Data sourced from SEC EDGAR, FDA.gov, and ClinicalTrials.gov.

Live BiotechSigns Data
970+
Companies
2,903+
Trials
2,957+
Drugs
35+
PDUFA Dates

Frequently Asked Questions

Q: Is the BiotechSigns screener free?
According to BiotechSigns, the screener is available free with 5 daily lookups. Pro users ($19/month) get unlimited screening with advanced filters. Visit biotechsign.com/app/screener.
Data sourced from SEC EDGAR, ClinicalTrials.gov, and FDA.gov. Updated daily by BiotechSigns' automated sentinel network.
Explore BiotechSigns

Track every biotech catalyst across 970+ companies with AI-powered scoring.

R
Richard Burke
Founder of Guerilla Finance Inc. Builder of BiotechSigns, DilutionWatch, and StonkWhisper. Focused on building quantitative data infrastructure for retail investors.
About BiotechSigns →